nadp has been researched along with Chlamydia pneumoniae Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, YJ; Cho, YS; Kim, TB; Lee, KY; Moon, HB; Moon, KA; Park, CS | 1 |
1 other study(ies) available for nadp and Chlamydia pneumoniae Infections
Article | Year |
---|---|
Chlamydophila pneumoniae triggers release of CCL20 and vascular endothelial growth factor from human bronchial epithelial cells through enhanced intracellular oxidative stress and MAPK activation.
Topics: Antioxidants; Asthma; Cell Line; Chemokine CCL20; Chlamydophila Infections; Chlamydophila pneumoniae; Enzyme Activation; Humans; NADP; Onium Compounds; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Respiratory Mucosa; Vascular Endothelial Growth Factor A | 2009 |